FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:579-580 February 25, 1993 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: In a randomized, controlled trial, Merlano et al. (Oct. 15 issue)¹ present data showing improved overall survival and progression-free survival among patients with advanced head and neck cancer treated by alternating radiotherapy and chemotherapy as compared with radiotherapy alone. Before this finding can be regarded as proof that combined treatment is superior to radiotherapy alone, an explanation of why the patients treated only with radiotherapy fared so badly is essential. Published data suggest that radiotherapy is capable of giving much better results, even in patients with advanced lesions.

Merlano et al. do not directly compare data on . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Merlano, M. (2006). Alternating chemotherapy and radiotherapy in locally advanced head and neck cancer: an alternative?. The Oncologist 11: 146-151 [Abstract] [Full Text]